US FDA says J&J's Ethicon issues correction related to surgical stapler
Summary
The U.S. drug regulator said on Friday Ethicon Endo-Surgery, a unit of Johnson & Johnson , issued a correction for certa...
The U.S. drug regulator said on Friday Ethicon Endo-Surgery, a unit of Johnson & Johnson , issued a correction for certain lots of a part related to its surgical stapler and classified the action as "most serious".
Tags
JNJ
Related Articles
Massive Headwinds Are on the Horizon for Pharmaceutical Stocks, but Here Are 2 That Could Weather the Storm
JNJ
PositiveBoston Jury Hits Johnson & Johnson with Record $42M Verdict in Asbestos Baby Powder Case
JNJ
NeutralJohnson & Johnson Launches VIRTUGUIDE™ AI-Powered Patient-Matched Lapidus System in U.S. to Reduce Complexity in Bunion Surgery for Millions
JNJ
Positive